SWFI First Read, January 18, 2018
Posted on 01/18/2018
Celgene Eyes Juno Therapeutics Celegene Corporation is in discussions to buy Seattle-based Juno Therapeutics. Juno Therapeutics has backers which include the Alaska Permanent Fund Corporation (APFC). Celgene has roughly US$ 12 billion in cash and already has a relationship with Juno Therapeutics. Auckland International Airport Sells Down Airport Holdings in NQA and Cairns Perron Investments […]
- Alaska Permanent Fund Corporation
- AP Pension
- Celegene
- Denmark
- Franklin Resources
- Infrastructure
- Juno Therapeutics
- Latin America
- Mexico
- PEMEX
